HEPACAM2 and gastric cancer: Notably, UGT2B15, previously associated with pathogenesis and prognosis of gastric cancer [32,33] and HEPACAM2, upregulated in patients with poor prognosis and linked to metastasis in various types of cancer, were highlighted.